Salman Rahman
Salman Rahman is a member of the International Trade Council and the CEO
of Vasgen Limited, a biotechnology and
pharmaceutical company. Vasgen is focused on developing innovative antibody
medicines to address unmet needs in the fields of ophthalmology, oncology, and
cardiovascular medicine. With a strong background in biochemistry and a passion
for improving patient quality of life, Salman transitioned from academia to the
biotech industry to translate his research findings into therapies.
Francis
Crick Institute) in London. His academic journey and postdoctoral training
provided him with valuable research experience and exposure to clinical
settings, working closely with physicians. As a Principal Investigator at
King's College London School of Medicine, Salman gained insights into the
business of pharmaceutical discovery and development, setting the stage for his
entrepreneurial venture.
Salman's
leadership at Vasgen has led to significant achievements. Securing prestigious
government funding of approximately £1 million validated the company's
technology and enabled the advancement of their lead drug development program.
Additionally, Salman's diligence and strategic approach resulted in the
successful prosecution of seven patents in major market jurisdictions. He takes
pride in his tenure as a Principal Investigator and the courage to transition
from academia to entrepreneurship.
Salman
has witnessed the dramatic evolution of the biotech and pharmaceutical
industry, particularly through the advancements in genomic science, medicine,
and the emergence of advanced therapies like cell and gene therapies. He
believes that genetic medicines will become a major modality in the global
pharmaceuticals market, alongside antibody medicines, in the next 5-10 years.
Salman is excited about the impact of advanced therapies, the expanding
understanding of pharmacogenomics, and the potential of AI in drug discovery.
For
aspiring professionals entering the industry, Salman emphasizes the importance
of building a strong network of peers and maintaining realistic expectations
regarding project timelines. When faced with setbacks and challenges, he
maintains a positive outlook and reminds himself that tomorrow is another day.
Salman
finds inspiration in the stories of Regeneron and Biontech, recognizing the
contributions and successes of their founding members. Outside of his
professional life, Salman has a deep interest in Islam as a practicing Muslim,
where he finds guidance in seeking cures for diseases. His hobbies include
sports and playing the guitar, nurturing his passion for music.
Salman
Rahman's commitment to advancing the biotech industry, developing innovative
therapies, and embracing new technologies positions him as a valuable member of
the International Trade Council, driving positive impact in the field of
biotechnology and pharmaceuticals.
